Skip to content
As investors pile into safe havens like cash and precious metals, a new gold rush is starting in one of the world’s most exciting mining hotspots...
A green light from the FDA can change everything for a healthcare company. This might just be the case for Eton Pharmaceuticals (ETON).On September 29, the company announced that the FDA had given Alkindi Sprinkle, its taste-neutral sprinkle (granule) formulation of hydrocortisone designed as a replacement therapy for pediatric adrenal insufficiency (AI), its stamp of approval.The verdict came on the previously scheduled PDUFA date. Additionally, six clinical studies, including the first and only interventional Phase 3 study of oral hydrocortisone for pediatric AI in neonates to children under eight years of age, served as the basis for the approval. Before the therapy got the FDA approval, oral hydrocortisone was only approved in tablet formulations of 5mg and stronger, with many pediatric patients requiring significantly lower doses. Alkindi Sprinkle will be available in 0.5mg, 1mg, 2mg and 5mg strengths, which will give clinicians flexibility to individualize dosing based on each patient’s needs...
Stock futures opened flat Wednesday evening heading into the first trading day of October and the fourth quarter....
What a ride 2020 has been so far for Nio (NIO). The Chinese EV manufacturer has taken the bull by the horns and has ridden it all the way to massive gains of 427%.There’s no doubt the hype on EV vehicles in 2020 is almost at fever pitch, with investors banking on the sector disrupting the entire auto industry over the coming years. However, as in any emerging industry there will be winners and losers.After initiating coverage of Nio earlier this month, the main pushback for Deutsche bank's Edison Yu from investors concerned the fact Nio “does not create the same level of excitement and loyalty in China that Tesla or the German luxury automakers command.”While Yu concedes that “given NIO is an upstart,” there is some truth to that assertion. The analyst points to recent data that shows “NIO is increasingly perceived by customers as a high-quality premium brand with...
(Bloomberg) -- More than 500 JPMorgan Chase & Co. employees got assistance from taxpayers aimed at helping businesses through the pandemic -- and dozens of them shouldn’t have, according to people with knowledge of the firm’s internal investigation.The discovery that so many people at the largest and most profitable U.S. bank had tapped the Economic Injury Disaster Loan program raised suspicions inside the company and set off a hasty probe, the full extent of which hasn’t been previously reported. Bloomberg broke the news earlier this month that at least some staff had abused the program.After noticing hundreds of employees had received government funds in their accounts, the bank began scrutinizing director-level employees and workers who received certain amounts, according to people with knowledge of the confidential review who spoke on condition they not be named. Of almost two dozen in that first group, the bank found five -- none of them...
Shyam Sankar, Palantir's COO, joined The Final Round to discuss the company's direct listing on the NYSE, his outlook for the company's revenue and addresses how the company works with the government....
Nikola Corporation recently issued a statement highlighting the direction of the company’s current strategies and its vision for the future. ...
